DBV Technologies (DBVT) Research & Development (2020 - 2026)
DBV Technologies (DBVT) reported Research & Development of $33.4 million for Q1 2026, up 55.35% year-over-year from $21.5 million in Q1 2025, and up 1.54% quarter-over-quarter from $32.9 million in Q4 2025.
DBV Technologies (DBVT) Research & Development (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 7 years of Research & Development data on file, last reported at $33.4 million in Q1 2026.
- Research & Development for Q1 2026 came in at $33.4 million, up 55.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $128.6 million (up 43.78% YoY), and the FY2025 annual result was $116.7 million, up 30.6% from the prior year.
- Research & Development rose to $33.4 million in Q1 2026 per DBVT's latest filing, from $32.9 million in the prior quarter.
- Over five years, Research & Development peaked at $33.7 million in Q2 2025 and troughed at $12.2 million in Q1 2022.
- A 5-year average of $22.1 million and a median of $21.4 million in 2024 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2023: Research & Development soared 153.69% in 2022, then sank 56.86% in 2023.
- A 5-year view of Research & Development shows it stood at $29.6 million in 2022, then slumped by 56.86% to $12.8 million in 2023, then surged by 47.98% to $18.9 million in 2024, then surged by 73.99% to $32.9 million in 2025, then increased by 1.54% to $33.4 million in 2026.
- Business Quant data shows DBVT's Research & Development at $33.4 million in Q1 2026, $32.9 million in Q4 2025, and $28.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | 33.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.40 Mn |
| Dec 31, 2025 | 32.89 Mn |
| Sep 30, 2025 | 28.62 Mn |
| Jun 30, 2025 | 33.69 Mn |
| Mar 31, 2025 | 21.50 Mn |
| Dec 31, 2024 | 18.90 Mn |
| Sep 30, 2024 | 23.66 Mn |
| Jun 30, 2024 | 25.37 Mn |
| Mar 31, 2024 | 21.40 Mn |
| Dec 31, 2023 | 12.78 Mn |
| Sep 30, 2023 | 13.80 Mn |
| Jun 30, 2023 | 17.62 Mn |
| Mar 31, 2023 | 16.04 Mn |
| Dec 31, 2022 | 29.61 Mn |
| Sep 30, 2022 | 15.10 Mn |
| Jun 30, 2022 | 18.61 Mn |
| Mar 31, 2022 | 12.22 Mn |
| Dec 31, 2021 | 11.67 Mn |
| Sep 30, 2021 | 16.32 Mn |
| Jun 30, 2021 | 20.18 Mn |